4.4 Review

C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis

Journal

NEUROSCIENCE LETTERS
Volume 713, Issue -, Pages -

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2019.134523

Keywords

Amyotrophic lateral sclerosis; Neurodegeneration; Immunology; C9ORF72; Proteostasis

Categories

Funding

  1. Amgen
  2. New York Stem Cell Foundation
  3. Tau Consortium
  4. NINDS [RO1 1R01NS097850-01]
  5. NINDS SBIR [1R44NS097094-01A1]
  6. Harrington Discovery Institute
  7. Alzheimer's Drug Discovery Foundation
  8. Association for Frontotemporal Dementia
  9. John Douglas French Alzheimer's Foundation

Ask authors/readers for more resources

Amyotrophic lateral sclerosis (ALS) is a rapidly progressing disease that affects upper and lower motor neurons eventually leading to paralysis and death by respiratory dysfunction. The most common genetic variant among ALS patients is a hexanucleotide repeat expansion within the first intron of the gene C9ORF72. This expansion elicits a complex cascade of events as a result of both gain- and loss-of-function mechanisms that contribute to neurodegeneration. Increasing evidence suggests that this repeat expansion in C9ORF72 also influences the immune homeostasis. In this review, we consolidate the current understanding of C9ORF72-mediated pathogenesis in both the central nervous system and peripheral immune system and propose mechanisms by which the immune system contributes to ALS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available